23.03.2013 Views

White Guide and Orange Guide Formatting Project - Pfizer

White Guide and Orange Guide Formatting Project - Pfizer

White Guide and Orange Guide Formatting Project - Pfizer

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

<strong>Orange</strong> <strong>Guide</strong> – Chapter 15: Non-Rebate Managed Care Customer Interactions<br />

Medication Compliance Programs<br />

Medication Compliance Programs, most commonly referred to as "refill reminder" or “adherence call”<br />

programs, are outreach programs directed at patients providing them with information about the<br />

product they are taking <strong>and</strong> reminding them of the importance of staying on therapy <strong>and</strong> to refill their<br />

prescription in order to get the full benefit of their medication.<br />

To ensure that a <strong>Pfizer</strong> customer is not improperly profiting from providing the disease management or<br />

medication compliance services <strong>Pfizer</strong> is paying for, which could be considered an improper<br />

inducement under the anti-kickback laws, the Service Agreement must follow several important rules:<br />

Where <strong>Pfizer</strong> provides the materials, the compensation to the customer must be equal to<br />

the FMV cost of conducting the reminder program.<br />

Where the customer creates the materials, the compensation to the customer must be equal<br />

to the FMV cost of creating <strong>and</strong> conducting the reminder program.<br />

Where possible, the FMV amount should be determined on a per-letter basis or per<br />

interaction basis <strong>and</strong>, as appropriate, the amount should be validated through internal<br />

benchmarking or an FMV assessment project.<br />

In addition to the above, all materials provided as part of either a Patient Education or<br />

Medication Compliance Program must be reviewed <strong>and</strong> approved by a <strong>Pfizer</strong> Review<br />

Committee.<br />

Co-Promote Programs<br />

Subject to HIPAA or any state medical marketing law requirements, <strong>Pfizer</strong> may enter into Service<br />

Agreements with customers for the distribution of non-routine formulary information about <strong>Pfizer</strong><br />

products to a customer’s members. Typically, these contracts compensate a customer for providing<br />

information to its members explaining that a <strong>Pfizer</strong> product has recently been added to the customer’s<br />

formulary or reminding them of the availability of <strong>Pfizer</strong> products on formulary.<br />

230<br />

Rev. 09/12<br />

Page 4 of 6

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!